Benefits
Small endurance gains from a betalain concentrate
Four small crossover trials tested 100 mg a day of a low-nitrate betalain-rich beetroot concentrate. Running time trials were about 2 to 3 percent faster in 22 triathletes and in 13 runners. In 28 cyclists, average power over a 30-minute time trial was marginally higher (231.6 vs 225.3 W, p=0.050) but distance covered and relative power did not differ, and blood nitric oxide did not rise, which is what separates this from a nitrate effect. Running economy and VO2max did not improve. The concentrate was supplied by its manufacturer in two of the four trials. Beetroot juice results belong to its nitrate, not to the pigments.
Artery function improved in one small trial
In 19 young healthy adults, 14 days of a betalain-rich dragon fruit powder supplying 33 mg betalains raised flow-mediated dilation, a measure of artery lining function, by about 1.3 percentage points, and reduced arterial stiffness. Blood pressure did not change in that trial. A separate pilot crossover in 48 men with coronary artery disease gave betalain-rich Opuntia stricta or red beetroot supplements for two weeks and reported lower homocysteine, glucose, cholesterol, triglycerides and blood pressure, though the authors judged only the homocysteine, LDL and non-HDL cholesterol changes large enough to matter clinically. Both trials are small and neither has been repeated.
Inflammatory markers unchanged in betalain trials
Betalains block NF-kB signalling and cut inflammatory cytokines in cell culture and in animals, but that has not carried over to people. The 100 mg concentrate trial in 28 cyclists found no change in inflammatory markers, and two trials of beetroot juice after damaging exercise found no change in C-reactive protein and no faster recovery. A 12-week beetroot juice trial in type 2 diabetes did report lower IL-6 and TNF-alpha, but it used a no-treatment comparison group rather than a placebo and the juice also supplied nitrate.
Antioxidant activity, mostly measured in the test tube
Betanin scavenges radicals about as well as vitamin C in laboratory assays. The clearest human signal is a crossover study in 18 healthy adults eating 500 g a day of betalain-rich cactus pear pulp for 2 weeks, which lowered several markers of oxidative damage while 150 mg a day of vitamin C did not. The 100 mg beetroot concentrate, by contrast, did not change oxidative stress markers in 28 cyclists. Absorption is low: about 0.3 percent of an oral dose is recovered intact in urine, and betanin was not detectable in blood after 250 mL of beetroot juice, so how much reaches tissues is unresolved.
Liver effects seen only in animals
The liver claim rests on rodent studies of alcohol and carbon tetrachloride injury, working through antioxidant activity and Phase 2 enzyme induction. No human trial has measured any liver outcome after betalain intake, so this is an animal finding and not a reason to take betalains for the liver.
Mechanism of action
Direct radical scavenging via betalain structure
Betanin and other betacyanins have unique nitrogen-containing chromophore structure that provides exceptional radical scavenging capacity. In hydrogen atom transfer assays, betanin shows IC50 values comparable to or better than vitamin C and E. Direct antioxidant mechanism is well-characterized in vitro.
Nrf2 activation and Phase 2 enzyme induction
Betalains activate Nrf2 transcription factor — upregulating Phase 2 detoxification enzymes (NQO1, HO-1, glutathione synthesis enzymes, glutathione-S-transferases). Mechanism for cellular antioxidant defense enhancement that outlasts direct radical scavenging effects.
NF-κB inhibition and anti-inflammatory cytokines
Betalains block NF-kB from entering the cell nucleus, which lowers transcription of pro-inflammatory genes such as TNF-alpha, IL-6, IL-1beta and COX-2. This is cell and animal work. Human trials of betalains have not shown a fall in inflammatory markers, so the pathway has not been demonstrated in people.
Endothelial function via nitrate-nitrite-NO pathway (co-occurring with betalains)
Beetroot's most important cardiovascular mechanism is through dietary nitrate conversion to nitric oxide via oral bacteria → nitrite → NO pathway. This is not a betalain mechanism but co-occurs with betalain consumption. Important to distinguish in evaluating beetroot vs purified betalain claims.
DNA protection (preclinical)
Betalains reduce oxidative damage to DNA in cell culture and in animals. What that means in people is unknown, because no human trial has measured DNA damage after betalain intake.
Clinical trials
Randomized double-blind crossover trial (Montenegro CF, Kwong DA, Minow ZA, Davis BA, Lozada CF, Casazza GA 2017, Appl Physiol Nutr Metab 42(2):166-172, PMID 28121183).
22 competitive triathletes (9 men, 13 women, mean age 38) took 100 mg/day of a betalain-rich beetroot concentrate containing no nitrate, or placebo, for 6 days, then cycled 40 minutes and ran a 10 km time trial, with a 5 km time trial 24 hours later.
The 10 km time trial was about 1.3 minutes faster on the concentrate (49.5 vs 50.8 minutes, p=0.03) and the next-day 5 km was faster in 17 of 22 participants (23.2 vs 23.9 minutes, p=0.003). Creatine kinase and next-day fatigue rose less. Heart rate and perceived exertion were unchanged. One small crossover trial of a single commercial concentrate, which was supplied by its manufacturer, two of whose scientists are acknowledged in the paper.
Randomized counterbalanced crossover trial (Mumford PW, Kephart WC, Romero MA, et al. 2018, Eur J Appl Physiol 118(11):2465-2476, PMID 30155761).
28 trained male cyclists took 100 mg/day of a betalain-rich beetroot concentrate or placebo for 7 days, with a 1-week washout, then completed a 30-minute cycling time trial.
Average absolute power was marginally higher on the concentrate (231.6 vs 225.3 W, p=0.050), a difference of under 3 percent, and efficiency improved over the final 5 minutes. Relative power, distance covered, lactate, glucose, inflammatory markers and oxidative stress markers did not differ. Plasma nitric oxide metabolites did not rise, which is why this result is read as a pigment effect rather than a nitrate effect.
Double-blind randomized crossover trial (Cheok A, Xu Y, Zhang Z, Caton PW, Rodriguez-Mateos A 2022, Am J Clin Nutr 115(5):1418-1431, PMID 35265960).
19 young, healthy, nonsmoking men and women took 24 g/day of whole dragon fruit powder providing 33 mg betalains, or a nutrient-matched placebo, for 14 days. 18 completed the trial.
Flow-mediated dilation, a measure of artery lining function, rose against placebo at 2, 3 and 4 hours after a dose (+0.8, +1.0 and +1.3 percentage points) and was still about 1.3 points higher at 14 days. Pulse-wave velocity fell at 3 hours and augmentation index improved at 14 days. Blood pressure did not change at any time point. These are surrogate measures of vessel function in young healthy people, not clinical outcomes in people with a diagnosed condition.